Association for Molecular Pathology v. Myriad Genetics
|Docket No.||Op. Below||Argument||Opinion||Vote||Author||Term|
|11-725||Fed. Cir.||Not Argued||Mar 26, 2012||TBD||TBD||OT 2011|
Issue: (1) Whether human genes are patentable; and (2) whether petitioners, who have been indisputably deterred by Myriad’s “active enforcement” of its patent rights, lack standing to challenge those patents absent evidence that they have been personally and directly threatened with an infringement action.
Plain English Summary:
Briefs and Documents
- Opinion below (Fed. Cir.)
- Petition for certiorari
- Brief in opposition
- Amicus brief of American Medical Association et al.
- Amicus brief of The National Women's Health Network et al.
- Amicus brief of Kaiser Permanente
- Amicus brief of AARP
- Amicus brief of Yale Law Information Society Project
- Amicus brief of Kali Murray and Erika George
- Amicus brief of the Canavan Foundation et al.
- Amicus brief of Cancer Counsel Australia et al.
- Amicus brief of Certain Academics in Law, Medicine, Health Policy and Clinical Genetics
- Amicus brief of of Knowledge Ecology International
- Reply for petitioners